AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma

Clinical trial NCT01085214 · COMPLETED

Trial details

NCT number: NCT01085214
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2010-03-01
Primary completion: 2012-03-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.